InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
3
Disclosed sells
4
T+90 hit rate
50%
T+90 mean return
+0.8%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by NINIVAGGI DANIEL A, Director. Director active across 6 companies, notably Indivior Pharmaceuticals, Inc.. Cumulatively, 26 disclosures have been recorded. Split: 3 buys · 4 sells. Total volume traded: €1.3m. History available since 19 May 2021. The latest transaction was filed on 15 May 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations26 total
1,042 sharesCommon StockSEC:0000950142-26-001984:0
17,178 shares@ US$31.21980.0080% mcap40.9% of flowCommon StockSEC:0000950142-26-001427:0
17,178 shares@ US$31.21980.0089% mcap40.9% of flowCommon StockSEC:0000950142-26-001427
6,518 shares0Common StockSEC:0001257599-26-000008:0
6,518 shares0Common StockSEC:0001257599-26-000008
6,142 sharesCommon StockSEC:0000950142-25-000984:0
5,577 sharesCommon StockSEC:0000950142-25-000040:0
4,722 shares0Common StockSEC:0000950142-24-002517:0
4,496 shares0Common StockSEC:0000950142-24-001846:0
15,927 shares0Common StockSEC:0000950142-24-001521:0
3,855 shares0Common StockSEC:0001062993-24-007948:0
31,111 sharesClass A common stockSEC:0001104659-24-035635:0
4,055 shares0Common StockSEC:0001062993-24-000443:0
17,178 shares0Common StockSEC:0001062993-23-012356:0
233,333 sharesClass A Common StockSEC:0001415889-22-009164:0
19,576 shares0Common StockSEC:0001062993-22-013892:0
5,810 shares0Common StockSEC:0000899243-22-009704:0
4,600 shares@ US$2.4435100.0% of flowClass A Common StockSEC:0001415889-22-002514:0
Ideal exit: 27 Nov 2022 (T+270)
8,825 shares0Common StockSEC:0001657853-21-000054:0
8,825 shares0Common StockSEC:0001657853-21-000054
9,844 shares@ US$7.5850.0% of flowCommon StockSEC:0001657853-21-000019
9,844 shares@ US$7.580.0038% mcap50.0% of flowCommon StockSEC:0001657853-21-000019:0
9,290 shares0Common StockSEC:0000899243-21-021151:0
9,290 shares0Common StockSEC:0000899243-21-021151
20,000 shares@ US$6.229.1% of flowCommon StockSEC:0000899243-21-020244
Ideal exit: 13 Feb 2022 (T+270)
25 of 26 declarations
About NINIVAGGI DANIEL A
Daniel A. Ninivaggi is a director at Indivior Pharmaceuticals, Inc.
